BioMarin Pharmaceutical Inc. – Filings and Transcripts

NASDAQ: BMRN
Share price (4/2/26): $55.50
Market cap (4/2/26): $10.7 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Ownership Filter

Vanguard Group Inc

Davis George Eric

Guyer Charles Greg

Hardy Alexander

News Filter

Reports Fourth Quarter and Full-Year 2025 Financial and Operating Results

Announces Closing of Private Offering of Senior Notes

Announces Pricing of Private Offering of Senior Notes and Completion of Syndication of New Senior Secured Term Loan Facility

Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC